DIANA PARNICZA: Open Payments
NPI 1841297967 · BARBOURSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 13 payments from 10 companies in 2025. Trend: 2023 $425 · 2024 $606 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $65 |
| ABBVIE INC. | 2 | $60 |
| Abbott Laboratories | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, QULIPTA, UBRELVY, FREESTYLE LIBRE 3, MOUNJARO, Veozah, GARDASIL 9, Wegovy.
Industry payments across WV — which companies pay providers there.
